[contact-form-7 id="78" title="Schedule a Visit"]

Schedule a Visit
Fill out the form, shoot us an email or give us a call.  We are here to answer your questions and schedule your visit.

Call us:
(424) 332-5550

Send an email:

  Have you tried at least two depression treatments without success? Your doctor may suggest ECT. However, after researching it, you may have concerns about the safety of the procedure and the side-effects that may be long-lasting. Treatment-resistant depression can be very frustrating but there is another treatment out there that may be the solution […]

  Are you suffering from alcohol or substance abuse? If so, you’re not alone, and ketamine therapy may be able to help. According to the National Institute on Alcohol Abuse and Alcoholism’s 2015 study, “15.1 million adults 18 and older (6.2% of this age group) had AUD (Alcohol Use Disorder). The Mayo Clinic defines AUD […]

Ketamine for Depression

What is Ketamine? Ketamine, also known as Ketalar, Ketaset, and Ketanest, is a medication that’s currently FDA approved only as an anesthetic but it’s showing great potential as a treatment for severe depression. In fact, numerous Ketamine Clinics have begun to appear throughout the United States to solve this problem. Depressed patients with stubborn symptoms get relief […]

Anxiety Spectrum

Abstract Anxiety disorders are among the most prevalent psychiatric conditions. Despite many proven pharmacological and non-pharmacological treatments available, high rates of partial response and low rates of long-term remission remain. Ketamine has been receiving increasing attention as an interventional treatment modality in psychiatry, especially among refractory conditions, including major depressive disorder. There is limited yet […]

kids ptsd

– Anna C. Donoghue, Mark G. Roback, Kathryn R. Cullen Abstract Ketamine, an N-methyl-D-aspartate–type glutamate receptor antagonist, has long been used for anesthesia and has recently been investigated for its rapid antidepressant effects in adults with treatment-resistant depression and posttraumatic stress disorder (PTSD). We report a case of a child with PTSD and episodes of severe aggression […]

Researchers looking into the use of ketamine say they have had a 75 per cent success rate in using it to treat long-term depression. “The results are startling,” says Melbourne University neuroscientist Associate Professor Graham Barrett, who has been studying depression for 30 years. “They’re not 100 per cent, there are people who don’t respond […]

chronic pain children

Background Chronic pain is common in children and adolescents and is often associated with severe functional disability and mood disorders. The pharmacological treatment of chronic pain in children and adolescents can be challenging, ineffective, and is mostly based on expert opinions and consensus. Ketamine, an N-methyl-D-aspartate receptor antagonist, has been used as an adjuvant for […]


– Maurizio Fava, Marlene P. Freeman, Martina Flynn, Heidi Judge, Bettina B. Hoeppner, Cristina Cusin, Dawn F. Ionescu, Sanjay J. Mathew, Lee C. Chang, Dan V. Iosifescu, James Murrough, Charles Debattista, Alan F. Schatzberg, Madhukar H. Trivedi, Manish K Jha, Gerard Sanacora, Samuel T. Wilkinson, George I. Papakostas Abstract Numerous placebo-controlled studies have demonstrated the […]

Social anxiety disorder

– Jerome H Taylor, Angeli Landeros-Weisenberger, Catherine Coughlin, Jilian Mulqueen, Jessica A Johnson, Daniel Gabriel, Margot O Reed, Ewgeni Jakubovski and Michael H Bloch Abstract Many patients with social anxiety disorder (SAD) experience inadequate symptom relief from available treatments. Ketamine is a potent N-methyl-D-aspartate (NMDA) receptor antagonist with a potentially novel mechanism of action for the […]

ocd symptoms

—Lauren LeBano Ketamine can quickly alleviate symptoms of obsessive-compulsive disorder (OCD) in patients with constant intrusive thoughts, and the drug’s effects can last for one to two weeks in certain patients. Researchers reported these findings in a poster presented at the American Psychiatric Association’s (APA) annual meeting. The rapid symptom relief seen from ketamine is […]


By Tracie White Geuris “Jerry” Rivas, a native of New York, was diagnosed with severe obsessive-compulsive disorder when he was 15. Obsessions with organizing and reorganizing the belongings in his bedroom — posters, comic books, videos — took over most of his life. Forced by germ obsessions to compulsively wash and rewash his hands, he […]

postpartum depression

By MEGHANA KESHAVAN @megkesh and DAMIAN GARDE @damiangarde An experimental drug touted as a breakthrough for treating severe postpartum depression is showing some promising results in a small clinical trial. Sage Therapeutics (SAGE), based in Cambridge, Mass., reported on Tuesday that 7 of the 10 women who took the drug in the trial experienced significant improvement in their depression within […]

overcome cocaine addiction

– Kevin Kunzmann MD Magazine Ketamine infusion, combined with mindfulness-based behavioral changes, has been shown to improve various aspects of treatment outcomes among rehabilitating cocaine-dependent individuals. The new findings from a randomized clinical trial show just a single infusion of the highly potent—yet controversial—NMDA receptor agonist is associated with significant patient improvements in cocaine abstinence at the […]

Abstract Objective: Subanesthetic ketamine doses have been shown to have rapid yet transient antidepressant effects in patients with treatment-resistant depression, which may be prolonged by repeated administration. The purpose of this study was to evaluate the antidepressant effects of a single ketamine infusion, a series of repeated ketamine infusions, and prolongation of response with maintenance […]


-Matt Hoffman The American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists have released consensus guidelines on the use of intravenous (IV) ketamine for the management of acute pain. “The use of ketamine for chronic pain has skyrocketed, and because it is an off-label use of […]

Ketamine IV

-Isaac V. Cohen, Tigran Makunts, Rabia Atayee & Ruben Abagyan Scientific Reports 7, article number 1450 (2017) Abstract Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight […]


Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain in patients who have not been helped by other treatments, suggests a study being presented at the ANESTHESIOLOGY® 2017 annual meeting. The study of 61 patients found that almost 75 percent experienced an improvement in their migraine intensity […]

ketamine is an effective treatment for OCD

By Tracie White Illustration by Kotryna Zukauskaite Geuris “Jerry” Rivas, a native of New York, was diagnosed with severe obsessive-compulsive disorder when he was 15. Obsessions with organizing and reorganizing the belongings in his bedroom — posters, comic books, videos — took over most of his life. Forced by germ obsessions to compulsively wash and […]


Highlights Preliminary evidence suggests that ketamine may be effective in addiction. Potential interacting mechanisms are enhancing neurogenesis and psychological therapies. Ketamine may reduce depressive symptoms in a risky window for addiction relapse. Abstract Ketamine is a dissociative anaesthetic drug which acts on the central nervous system chiefly through antagonism of the n-methyl-d-aspartate (NMDA) receptor. Recently, ketamine has attracted attention as a rapid-acting anti-depressant but other studies have also […]

treating depression

The total economic burden of MDD is now estimated to be $210.5 billion per year, representing a 21.5% increase from $173.2 billion per year in 2005. Of particular interest is that nearly half (48%-50%) of these costs are attributed to the workplace, including absenteeism (missed days from work) and presenteeism (reduced productivity while at work), whereas 45%-47% are due to direct medical costs (e.g., outpatient and inpatient medical services, pharmacy costs), which are shared by employers, employees, and society. About 5% of the total expenditures are related to suicide.


Ketamine’s antidepressive effects require activation of opioid receptors in the brain, a new Stanford study shows. The surprising finding may alter how new antidepressants are developed and administered in order to mitigate the risk of opioid dependence.

Yale University School of Medicine is a leader in research demonstrating how Ketamine is a highly effective treatment for depression.

Now there is a new FDA drug approved to also help treat depression called Spravato. Call (424) 332-5550 to learn more.

Call Us
Free Consult